Education Intervention to Increase Naltrexone Use Among Adult Inpatients With Alcohol Use Disorder

被引:1
|
作者
Ipsarides, Jason [1 ,2 ]
机构
[1] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI USA
[2] Med Coll Wisconsin, Dept Psychiat & Behav ioral Med, 8920 W Connell Court,Suite B510, Milwaukee, WI 53132 USA
关键词
PHARMACOTHERAPY; DEPENDENCE;
D O I
10.3928/02793695-20230424-03
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Alcohol use disorder (AUD) accounts for high rates of global deaths, disability, and health care spending. Naltrexone is an opioid antagonist used to reduce alcohol cravings. Despite demonstrated safety and efficacy, naltrexone is highly under-utilized in a variety of health care settings. The current quality improvement (QI) project aimed to increase knowledge and prescribing behaviors of naltrexone. A chart review of a purposive convenience sample was performed to determine the impact of the intervention. Staff participants completed a pre/posttest and a post-module survey. The primary objectives of the QI project were to increase the number of patients with AUD discharged with a prescription for naltrexone by 5% and achieve 50% staff participation in the online module, pre/posttest, and post -module survey. [Journal of Psychosocial Nursing and Mental Health Services, xx(x), xx-xx.]
引用
收藏
页码:10 / 14
页数:5
相关论文
共 50 条
  • [31] FEASIBILITY AND ACCEPTABILITY OF A GRATITUDE INTERVENTION AMONG INDIVIDUALS IN TREATMENT FOR AN ALCOHOL USE DISORDER
    Krentzman, A. R.
    Mannella, K. A.
    Hassett, A. L.
    Barnett, N.
    Meyer, P. S.
    Cranford, J. A.
    Brower, K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 55A - 55A
  • [32] Correlates of post-hospitalization naltrexone adherence for alcohol use disorder
    Y.Bernstein, Eden
    Magane, Kara M.
    Dukes, Kimberly A.
    Palfai, Tibor P.
    Lee, Joo H.
    Saitz, Richard
    Samet, Jeffrey H.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 265
  • [33] THE EFFECT OF A GRATITUDE INTERVENTION ON MOOD AMONG INDIVIDUALS IN TREATMENT FOR AN ALCOHOL USE DISORDER
    Krentzman, A. R.
    Mannella, K. A.
    Hassett, A. L.
    Barnett, N.
    Meyer, P. S.
    Cranford, J. A.
    Brower, K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 55A - 55A
  • [34] BARRIERS TO INITIATING NALTREXONE AT HOSPITAL DISCHARGE IN ADULTS WITH ALCOHOL USE DISORDER
    Kim, S.
    Chen, C. A.
    Cheng, D. M.
    Meli, S.
    Lee, H.
    Palfai, T.
    Samet, J. H.
    Saitz, R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 246A - 246A
  • [35] PHARMACOGENOMICS OF ACAMPROSATE AND NALTREXONE THERAPY RESPONSE IN ALCOHOL USE DISORDER (AUD)
    Zhu, X.
    Liu, D.
    Gao, H.
    Ho, M.
    Nguyen, T.
    Coombes, B.
    Biernacka, J.
    Karpyak, V.
    Weinshilboum, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S61 - S61
  • [36] Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population
    Vergara-Quispe, Romina
    Marti-Aguado, David
    Bataller, Ramon
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (02)
  • [37] Sugar intake and craving during alcohol withdrawal in alcohol use disorder inpatients
    Alarcon, Regis
    Tiberghien, Margaux
    Trouillet, Raphael
    Pelletier, Stephanie
    Luquiens, Amandine
    Ahmed, Serge H.
    Nalpas, Bertrand
    Alaux-Cantin, Stephanie
    Naassila, Mickael
    Perney, Pascal
    ADDICTION BIOLOGY, 2021, 26 (02)
  • [38] Medication Adherence Among Patients Who Initiated Naltrexone for Treatment of Alcohol Use Disorder in the Emergency Department
    Forsgren, E.
    Perez, Y.
    Salazar, D.
    Cuervo, L. L.
    Novak, N.
    McCollough, M.
    Taira, B.
    ANNALS OF EMERGENCY MEDICINE, 2023, 82 (04) : S154 - S155
  • [39] ALCOHOL USE DISORDER TREATMENT AND SUBSEQUENT MORTALITY AMONG PATIENTS WITH CIRRHOSIS AND ALCOHOL USE DISORDER
    Alexandre, Wheytnie
    Haseeb, Muhammad
    Agbalajobi, Olufunso M.
    Zhang, Grace Yuan
    Jonassaint, Naudia L.
    Bataller, Ramon
    Rogal, Shari S.
    HEPATOLOGY, 2020, 72 : 150A - 151A
  • [40] Efficacy and tolerability of naltrexone in patients with Internet gaming disorder and comorbid alcohol use disorder
    Vasiliu, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S352 - S353